Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Firms Stand To Lose Market Opportunities If Health Care Reform Dies

This article was originally published in The Gray Sheet

Executive Summary

With the fate of comprehensive health care reform in serious doubt at the eleventh hour, many in the device industry may be breathing a sigh of relief that the device tax could be avoided or at least lessened. But if the reform bill dies, the industry will also lose out on the potential 30 million additional health care customers slated to gain insurance under its provisions

You may also be interested in...



Supreme Court Health Reform Oral Arguments Leave Open Questions

Device firms should not stop preparing for the 2.3% excise tax, scheduled to take effect next January. Still, justices during oral arguments March 26-28 did not take off the table the prospect of ruling the entire health care reform legislation void.

Sebelius Defends Device Tax And HHS 2012 Budget Request On The Hill

Republican efforts to repeal the device tax were met with resistance from Health and Human Services Secretary Kathleen Sebelius, who defended the tax during a Feb. 16 House Ways and Means Committee hearing on the president's fiscal year 2012 budget request.

Sebelius Defends Device Tax And HHS 2012 Budget Request On The Hill

Republican efforts to repeal the device tax were met with resistance from Health and Human Services Secretary Kathleen Sebelius, who defended the tax during a Feb. 16 House Ways and Means Committee hearing on the president's fiscal year 2012 budget request.

Related Content

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel